The stock of AMARANTUS BIOSCIENCE HOLDINGS IN (OTCMKTS:AMBS) registered an increase of 5722.22% in short interest. AMBS’s total short interest was 52,400 shares in September as published by FINRA. Its up 5722.22% from 900 shares, reported previously. With 667,900 shares average volume, it will take short sellers 0 days to cover their AMBS’s short positions. The stock increased 1.14% or $0.0006 on September 13, hitting $0.0531. About 264,423 shares traded hands. Amarantus Bioscience Holdings Inc (OTCMKTS:AMBS) has declined 76.77% since February 8, 2016 and is downtrending. It has underperformed by 93.26% the S&P500.
Amarantus Bioscience Holdings, Inc. is a biopharmaceutical holding company. The company has a market cap of $3.70 million. The Firm has approximately three operating divisions: the diagnostics division, the therapeutics division and the drug discovery division. It currently has negative earnings. It owns licenses to various product candidates in the therapeutic and diagnostic sectors of the life sciences industry.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.